56 related articles for article (PubMed ID: 27802437)
1. Valproic Acid Promotes Human Glioma U87 Cells Apoptosis and Inhibits Glycogen Synthase Kinase-3β Through ERK/Akt Signaling.
Zhang C; Liu S; Yuan X; Hu Z; Li H; Wu M; Yuan J; Zhao Z; Su J; Wang X; Liao Y; Liu Q
Cell Physiol Biochem; 2016; 39(6):2173-2185. PubMed ID: 27802437
[TBL] [Abstract][Full Text] [Related]
2. Modulation of PI3K/Akt/GSK3β signaling cascade through G protein-coupled receptor 55 (GPR55) activation: Prenatal lysophosphatidylinositol attenuates valproic acid-induced synaptic abnormalities and mitochondrial dysfunction.
Ahmed S; Abir AH; Sharmin O; Khurshid N; Akter A; Nakshy NT; Hasan MM; Yesmine S; Rahman M
Life Sci; 2023 Dec; 334():122195. PubMed ID: 37866808
[TBL] [Abstract][Full Text] [Related]
3. Caffeine inhibits cell proliferation and regulates PKA/GSK3β pathways in U87MG human glioma cells.
Ku BM; Lee YK; Jeong JY; Ryu J; Choi J; Kim JS; Cho YW; Roh GS; Kim HJ; Cho GJ; Choi WS; Kang SS
Mol Cells; 2011 Mar; 31(3):275-9. PubMed ID: 21229324
[TBL] [Abstract][Full Text] [Related]
4. Melatonin alleviates valproic acid-induced neural tube defects by modulating Src/PI3K/ERK signaling and oxidative stress.
Liang Y; Wang Y; Zhang X; Jin S; Guo Y; Yu Z; Xu X; Shuai Q; Feng Z; Chen B; Liang T; Ao R; Li J; Zhang J; Cao R; Zhao H; Chen Z; Liu Z; Xie J
Acta Biochim Biophys Sin (Shanghai); 2024 Jan; 56(1):23-33. PubMed ID: 38062774
[TBL] [Abstract][Full Text] [Related]
5. Dual Functional Mesoporous Silicon Nanoparticles Enhance the Radiosensitivity of VPA in Glioblastoma.
Zhang H; Zhang W; Zhou Y; Jiang Y; Li S
Transl Oncol; 2017 Apr; 10(2):229-240. PubMed ID: 28193559
[TBL] [Abstract][Full Text] [Related]
6. Valproic acid in glioma: Will the anticancer issue ever be solved?
van der Meer PB; Koekkoek JAF
Neurooncol Pract; 2023 Feb; 10(1):1-2. PubMed ID: 36659971
[No Abstract] [Full Text] [Related]
7. 8-Hydroxydaidzein Induces Apoptosis and Inhibits AML-Associated Gene Expression in U-937 Cells: Potential Phytochemical for AML Treatment.
Wu PS; Wang CY; Hsu HJ; Yen JH; Wu MJ
Biomolecules; 2023 Oct; 13(11):. PubMed ID: 38002257
[TBL] [Abstract][Full Text] [Related]
8. Revisiting Concurrent Radiation Therapy, Temozolomide, and the Histone Deacetylase Inhibitor Valproic Acid for Patients with Glioblastoma-Proteomic Alteration and Comparison Analysis with the Standard-of-Care Chemoirradiation.
Krauze AV; Zhao Y; Li MC; Shih J; Jiang W; Tasci E; Cooley Zgela T; Sproull M; Mackey M; Shankavaram U; Tofilon P; Camphausen K
Biomolecules; 2023 Oct; 13(10):. PubMed ID: 37892181
[TBL] [Abstract][Full Text] [Related]
9. Signaling Pathways Involved in the Neuroprotective Effect of Osthole: Evidence and Mechanisms.
Singh L; Bhatti R
Mol Neurobiol; 2024 Feb; 61(2):1100-1118. PubMed ID: 37682453
[TBL] [Abstract][Full Text] [Related]
10. N-acetylcysteine improves autism-like behavior by recovering autophagic deficiency and decreasing Notch-1/Hes-1 pathway activity.
Zhang YH; Wang T; Li YF; Deng YN; He XL; Wang LJ
Exp Biol Med (Maywood); 2023 Jun; 248(11):966-978. PubMed ID: 37377100
[TBL] [Abstract][Full Text] [Related]
11. Introducing HDAC-Targeting Radiopharmaceuticals for Glioblastoma Imaging and Therapy.
Everix L; Seane EN; Ebenhan T; Goethals I; Bolcaen J
Pharmaceuticals (Basel); 2023 Feb; 16(2):. PubMed ID: 37259375
[TBL] [Abstract][Full Text] [Related]
12. A comprehensive review on pharmacological applications and drug-induced toxicity of valproic acid.
Safdar A; Ismail F
Saudi Pharm J; 2023 Feb; 31(2):265-278. PubMed ID: 36942277
[TBL] [Abstract][Full Text] [Related]
13. Antitumor Potential of Antiepileptic Drugs in Human Glioblastoma: Pharmacological Targets and Clinical Benefits.
Stella M; Baiardi G; Pasquariello S; Sacco F; Dellacasagrande I; Corsaro A; Mattioli F; Barbieri F
Biomedicines; 2023 Feb; 11(2):. PubMed ID: 36831117
[TBL] [Abstract][Full Text] [Related]
14. Liposomes Loaded with Amaranth Unsaponifiable Matter and Soybean Lunasin Prevented Melanoma Tumor Development Overexpressing Caspase-3 in an In Vivo Model.
Castañeda-Reyes ED; Perea-Flores MJ; Dávila-Ortiz G; Gonzalez de Mejia E
Pharmaceutics; 2022 Oct; 14(10):. PubMed ID: 36297649
[TBL] [Abstract][Full Text] [Related]
15. Anti‑tumor effects of anti‑epileptic drugs in malignant glioma cells.
Yagi C; Tatsuoka J; Sano E; Hanashima Y; Ozawa Y; Yoshimura S; Yamamuro S; Sumi K; Hara H; Katayama Y; Yoshino A
Oncol Rep; 2022 Dec; 48(6):. PubMed ID: 36281939
[TBL] [Abstract][Full Text] [Related]
16. Chalcone 9X Contributed to Repressing Glioma Cell Growth and Migration and Inducing Cell Apoptosis by Reducing FOXM1 Expression In Vitro and Repressing Tumor Growth In Vivo.
Li C; Wang R; Guo W; Feng X; Guan N
Biomed Res Int; 2022; 2022():8638085. PubMed ID: 35978634
[TBL] [Abstract][Full Text] [Related]
17. The Diagnostic and Prognostic Values of HOXA Gene Family in Kidney Clear Cell Renal Cell Carcinoma.
Zong X; Fu J; Wang Z; Wang Q
J Oncol; 2022; 2022():1762637. PubMed ID: 35342423
[TBL] [Abstract][Full Text] [Related]
18. Hippo Pathway in Regulating Drug Resistance of Glioblastoma.
Casati G; Giunti L; Iorio AL; Marturano A; Galli L; Sardi I
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948224
[TBL] [Abstract][Full Text] [Related]
19. Drug Repurposing for Glioblastoma and Current Advances in Drug Delivery-A Comprehensive Review of the Literature.
Alomari S; Zhang I; Hernandez A; Kraft CY; Raj D; Kedda J; Tyler B
Biomolecules; 2021 Dec; 11(12):. PubMed ID: 34944514
[TBL] [Abstract][Full Text] [Related]
20. ERK: A Double-Edged Sword in Cancer. ERK-Dependent Apoptosis as a Potential Therapeutic Strategy for Cancer.
Sugiura R; Satoh R; Takasaki T
Cells; 2021 Sep; 10(10):. PubMed ID: 34685488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
